Also this year- updates from ESMO!
The program is available online here
Subscribe to:
Post Comments (Atom)
ESMO 2018 Congress TV: Protecting Patients from Fake News with Gilliosa ...
Fake News and Pseudoscience are dangerous for patients. So very pleased and incredibly proud to see Gilly's session covered on the ...
-
1. SD101- Tol9 receptor agonist plus PD1 in - not sure why you would do that- PD1 naive patients data for PDL1 status needs to be verifi...
-
Fake News and Pseudoscience are dangerous for patients. So very pleased and incredibly proud to see Gilly's session covered on the ...
-
Why treating early stage patients? Early stage patients have all the favourable disease outcomes that we know from Stage 4 cancer immu...
No comments:
Post a Comment